GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » Debt-to-Revenue

TMC Life Sciences Bhd (XKLS:0101) Debt-to-Revenue : 0.61 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

TMC Life Sciences Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM21.7 Mil. TMC Life Sciences Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM188.1 Mil. TMC Life Sciences Bhd's annualized Revenue for the quarter that ended in Mar. 2024 was RM344.3 Mil. TMC Life Sciences Bhd's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.61.


TMC Life Sciences Bhd Debt-to-Revenue Historical Data

The historical data trend for TMC Life Sciences Bhd's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMC Life Sciences Bhd Debt-to-Revenue Chart

TMC Life Sciences Bhd Annual Data
Trend May13 May14 May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.87 0.86 0.70

TMC Life Sciences Bhd Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.65 0.58 0.57 0.61

Competitive Comparison of TMC Life Sciences Bhd's Debt-to-Revenue

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Debt-to-Revenue falls into.



TMC Life Sciences Bhd Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

TMC Life Sciences Bhd's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(17.691 + 201.368) / 311.443
=0.70

TMC Life Sciences Bhd's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(21.687 + 188.106) / 344.292
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


TMC Life Sciences Bhd Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TMC Life Sciences Bhd (XKLS:0101) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd (XKLS:0101) Headlines

No Headlines